-
structures chosen from understanding of initial series of compounds and their performance from MRC grant MR/T015845/1) in terms of measurements of efficacy using a validated in vivo model of respiratory
-
populations and space, particularly for vulnerable and disadvantaged populations. The RA will lead literature review searches to identify the historical, structural, and contextual drivers of disease risk and
-
populations and space, particularly for vulnerable and disadvantaged populations. The RA will lead literature review searches to identify the historical, structural, and contextual drivers of disease risk and
Enter an email to receive alerts for structures-"https:"-"https:"-"https:" positions